RadNet is an American radiology firm. The company operates outpatient diagnostic imaging services. Headquartered in Los Angeles, California, RadNet is the largest operator of freestanding, fixed-site diagnostic imaging centers in the United States, based on the number of locations and annual imaging revenue. As of 2025, the company owns and/or operates over 400 imaging centers across Arizona, California, Delaware, Florida, Maryland, New Jersey, New York, and Texas.
trading_symbol | registrant_name | time | price | change | percentage_change |
---|---|---|---|---|---|
RDNT | RadNet, Inc. | 2025-10-16 18:36:36 | 77.73 | 0.34 | 0.44 |
trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
RDNT | 0000790526 | RadNet, Inc. | US7504911022 | 529900RECG94V2IZJ970 | 133326724 | Nasdaq | 8071 | Services-Medical Laboratories | 1231 | DE | 1510 COTNER AVE | LOS ANGELES | CA | 90025 | UNITED STATES | US | 3104787808 | 1510 COTNER AVE, LOS ANGELES, CA, 90025 | 1510 COTNER AVE, LOS ANGELES, CA, 90025 | RadNet, Inc. | — | 1981 | — | 11,000 | http://radnet.com | 4,200,000,000 | 75,067,102 | 76,916,062 | RadNet is an American radiology firm. The company operates outpatient diagnostic imaging services. Headquartered in Los Angeles, California, RadNet is the largest operator of freestanding, fixed-site diagnostic imaging centers in the United States, based on the number of locations and annual imaging revenue. As of 2025, the company owns and/or operates over 400 imaging centers across Arizona, California, Delaware, Florida, Maryland, New Jersey, New York, and Texas. | 2025-10-10 20:06:41 |
Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
---|---|---|---|---|---|---|
2024 | 4,200,000,000 | 2,100,000,000 | 100 | 74,041,715 | 5,566,272 | 8.1289 |
2023 | 2,100,000,000 | 1,100,000,000 | 110 | 68,475,443 | 10,639,199 | 18.3954 |
2022 | 1,000,000,000 | -500,000,000 | -33.3333 | 57,836,244 | 1,652,567 | 2.9414 |
Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
---|---|---|---|---|---|---|---|---|
Cornelis Wesdorp | Chief Executive Officer, President | 2024 | 153,341 | 0 | 4,160,469 | — | 13,595 | 4,327,405 |
Stephen M. Forthuber | Chief Operating Officer, President | 2024 | 800,000 | 650,000 | 650,017 | — | 52,882 | 2,152,899 |
Howard G. Berger, M.D. | Chief Executive Officer, President | 2024 | 3,000,000 | 4,000,000 | 2,000,004 | — | 76,433 | 9,076,437 |
Mark D. Stolper | Chief Financial Officer, Executive Vice President | 2024 | 700,000 | 575,000 | 574,982 | — | 33,157 | 1,883,139 |
Norman R. Hames | Chief Operating Officer, President | 2024 | 800,000 | 650,000 | 650,017 | — | 36,486 | 2,136,503 |
Fiscal Year | Employee Count |
---|---|
2018 | 76 |
2017 | 76 |
2016 | 67 |
Fiscal Year | 2024 | 2023 | 2022 |
---|---|---|---|
Revenue | 1,829,664,000 | 1,616,630,000 | 1,430,061,000 |
Cost Of Revenue | — | — | — |
Gross Profit | — | — | — |
Research And Development Expenses | — | — | — |
General And Administrative Expenses | — | — | — |
Operating Expenses | 1,725,043,000 | 1,517,933,000 | 1,383,698,000 |
Operating Income | 104,621,000 | 98,697,000 | 46,363,000 |
Net Income | 2,793,000 | 3,044,000 | 10,650,000 |
Earnings Per Share Basic | 0.04 | 0.05 | 0.19 |
Earnings Per Share Diluted | 0.04 | 0.05 | 0.17 |
Weighted Average Shares Outstanding Basic | 73,037,237 | 63,580,059 | 56,293,336 |
Weighted Average Shares Outstanding Diluted | 74,762,332 | 64,658,299 | 57,320,870 |
Fiscal Year | 2024 | 2023 | 2022 |
---|---|---|---|
Cash And Cash Equivalents | 740,020,000 | 342,570,000 | 127,834,000 |
Marketable Securities Current | — | — | — |
Accounts Receivable | 185,821,000 | 163,707,000 | 166,357,000 |
Inventories | — | — | — |
Non Trade Receivables | — | — | — |
Other Assets Current | — | — | — |
Total Assets Current | 1,019,252,000 | 579,276,000 | 367,184,000 |
Marketable Securities Non Current | — | — | — |
Property Plant And Equipment | 694,791,000 | 604,401,000 | 565,961,000 |
Other Assets Non Current | 13,000,000 | 9,000,000 | 24,100,000 |
Total Assets Non Current | 232,750,000 | 224,936,000 | 134,694,000 |
Total Assets | 3,286,690,000 | 2,690,473,000 | 2,433,907,000 |
Accounts Payable | 96,450,000 | 122,888,000 | 102,678,000 |
Deferred Revenue | 3,288,000 | 4,647,000 | 4,021,000 |
Short Term Debt | 24,692,000 | 17,974,000 | 12,400,000 |
Other Liabilities Current | 153,252,000 | 124,059,000 | 181,574,000 |
Total Liabilities Current | 479,712,000 | 437,452,000 | 466,723,000 |
Long Term Debt | 1,016,266,000 | 830,042,000 | 851,744,000 |
Other Liabilities Non Current | 3,785,000 | 6,721,000 | 23,015,000 |
Total Liabilities Non Current | 70,241,000 | 70,834,000 | 37,952,000 |
Total Liabilities | 2,153,280,000 | 1,877,114,000 | 1,942,455,000 |
Common Stock | 7,000 | 7,000 | 6,000 |
Retained Earnings | -76,785,000 | -79,578,000 | -82,622,000 |
Accumulated Other Comprehensive Income | -9,061,000 | -12,484,000 | -20,677,000 |
Total Shareholders Equity | 902,308,000 | 630,695,000 | 332,995,000 |
Fiscal Year | 2024 | 2023 | 2022 |
---|---|---|---|
Depreciation And Amortization | 12,500,000 | 12,200,000 | 10,100,000 |
Share Based Compensation Expense | 29,833,000 | 26,785,000 | 23,770,000 |
Other Non Cash Income Expense | -8,006,000 | -2,187,000 | -2,529,000 |
Change In Accounts Receivable | 21,767,000 | -2,650,000 | 30,078,000 |
Change In Inventories | — | — | — |
Change In Non Trade Receivables | — | — | — |
Change In Other Assets | — | — | — |
Change In Accounts Payable | 37,117,000 | 15,086,000 | 49,778,000 |
Change In Other Liabilities | — | — | — |
Cash From Operating Activities | 233,023,000 | 220,863,000 | 146,417,000 |
Purchases Of Marketable Securities | — | — | — |
Sales Of Marketable Securities | — | — | — |
Acquisition Of Property Plant And Equipment | 188,070,000 | 176,600,000 | 119,451,000 |
Acquisition Of Business | — | — | — |
Other Investing Activities | — | — | — |
Cash From Investing Activities | -233,070,000 | -201,470,000 | -246,949,000 |
Tax Withholding For Share Based Compensation | — | — | — |
Payments Of Dividends | — | — | — |
Issuance Of Common Stock | 218,385,000 | 245,832,000 | — |
Repurchase Of Common Stock | — | — | — |
Issuance Of Long Term Debt | 863,757,000 | — | — |
Repayment Of Long Term Debt | 1,900,000 | 0 | 0 |
Other Financing Activities | 667,000 | 142,000 | 294,000 |
Cash From Financing Activities | 397,950,000 | 195,635,000 | 93,647,000 |
Change In Cash | 397,450,000 | 214,736,000 | -6,772,000 |
Cash At End Of Period | 740,020,000 | 342,570,000 | 127,834,000 |
Income Taxes Paid | 4,170,000 | 1,587,000 | 587,000 |
Interest Paid | 84,601,000 | 64,695,000 | 39,151,000 |
Fiscal Year | 2024 | 2023 | 2022 |
---|---|---|---|
Earnings Per Share | 0.04 | 0.05 | 0.19 |
Price To Earnings Ratio | 1,746 | 695.4 | 99.1053 |
Earnings Growth Rate | -20 | -73.6842 | -59.5745 |
Price Earnings To Growth Ratio | -87.3 | -9.4376 | -1.6636 |
Book Value Per Share | 15.5182 | 12.7927 | 8.7302 |
Price To Book Ratio | 4.5005 | 2.718 | 2.1569 |
Ebitda | 99,312,000 | 81,314,000 | 72,178,000 |
Enterprise Value | 5,401,858,632.08 | 2,716,124,651.43 | 1,796,313,516.88 |
Dividend Yield | — | — | — |
Dividend Payout Ratio | — | — | — |
Debt To Equity Ratio | 1.1537 | 1.3446 | 2.5951 |
Capital Expenditures | 102,890,000 | 50,640,000 | — |
Free Cash Flow | 130,133,000 | 170,223,000 | — |
Return On Equity | 0.0031 | 0.0048 | 0.032 |
One Year Beta | 1.4708 | 1.1873 | 1.2944 |
Three Year Beta | 1.3079 | 1.2615 | 1.3948 |
Five Year Beta | 1.3853 | 1.3417 | 1.2617 |
Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
---|---|---|---|---|---|
Katz David Jeffrey | EVP and Chief Legal Officer | 2025-09-11 | 4,593 | D | 82,181 |
Wesdorp Cornelis | Pres & CEO, Digital Health | 2025-09-11 | 500 | D | 53,495 |
HAMES NORMAN R | Pres and COO-West Operations | 2025-09-10 | 10,000 | D | 239,183 |
Wesdorp Cornelis | Pres & CEO, Digital Health | 2025-09-09 | 500 | D | 53,995 |
HAMES NORMAN R | Pres and COO-West Operations | 2025-08-27 | 5,000 | D | 19,889 |
Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
---|---|---|---|---|
CWM, LLC | 2025-09-30 | 37,000 | 480 | 77.0833 |
Inspire Investing, LLC | 2025-09-30 | 451,163 | 5,920 | 76.21 |
HARBOR CAPITAL ADVISORS, INC. | 2025-09-30 | 9,480,000 | 124,390 | 76.2119 |
Vontobel Holding Ltd. | 2025-09-30 | 559,534 | 7,342 | 76.21 |
HIGHLINE WEALTH PARTNERS LLC | 2025-09-30 | 74,610 | 979 | 76.2104 |
Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
---|---|---|---|---|---|---|
TRUST FOR PROFESSIONAL MANAGERS | 2025-08-31 | Column Small Cap Fund | CFSLX | 14,303 | 1,026,383.28 | 0.2142 |
ETF Series Solutions | 2025-07-31 | AAM SAWGRASS U.S. SMALL CAP QUALITY GROWTH ETF | SAWS | 269 | 14,722.37 | 0.9409 |
AMERICAN PENSION INVESTORS TRUST | 2025-07-31 | Institutional Class | APGRX | 5,350 | 292,805.5 | 0.3165 |
AMERICAN PENSION INVESTORS TRUST | 2025-07-31 | Class A Shares | AFGGX | 5,350 | 292,805.5 | 0.3165 |
AMERICAN PENSION INVESTORS TRUST | 2025-07-31 | Class L Shares | APITX | 5,350 | 292,805.5 | 0.3165 |